1. Home
  2. GTE vs MDWD Comparison

GTE vs MDWD Comparison

Compare GTE & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gran Tierra Energy Inc.

GTE

Gran Tierra Energy Inc.

HOLD

Current Price

$8.06

Market Cap

209.3M

Sector

Energy

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$17.10

Market Cap

193.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTE
MDWD
Founded
2003
2000
Country
Canada
Israel
Employees
N/A
N/A
Industry
Oil & Gas Production
Medicinal Chemicals and Botanical Products
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
209.3M
193.3M
IPO Year
2007
2013

Fundamental Metrics

Financial Performance
Metric
GTE
MDWD
Price
$8.06
$17.10
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$36.00
AVG Volume (30 Days)
680.0K
101.2K
Earning Date
05-01-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$374,460,000.00
N/A
Revenue This Year
$1.39
$48.88
Revenue Next Year
$2.84
$35.08
P/E Ratio
N/A
N/A
Revenue Growth
41.99
N/A
52 Week Low
$3.09
$14.90
52 Week High
$9.74
$22.51

Technical Indicators

Market Signals
Indicator
GTE
MDWD
Relative Strength Index (RSI) 51.73 50.90
Support Level $3.75 $16.77
Resistance Level $9.74 $18.71
Average True Range (ATR) 0.49 0.88
MACD -0.15 0.12
Stochastic Oscillator 30.21 69.04

Price Performance

Historical Comparison
GTE
MDWD

About GTE Gran Tierra Energy Inc.

Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. A majority of its revenue is derived from its operations in Colombia.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: